source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
PMC |
7199903 |
Site-specific glycan analysis of the SARS-CoV-2 spike
SARS-CoV-2 spike protein, elaborated
Vaccine |
17.9 KB |
2020-09-27 |
|
39 |
|
83 |
2021-01-19
|
PMC |
7205724 |
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppr |
29.5 KB |
2020-12-29 |
|
40 |
|
90 |
2021-01-19
|
PMC |
7228307 |
Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
FcγR an |
60.9 KB |
2020-09-27 |
|
37 |
|
2 |
2021-01-19
|
PMC |
7253482 |
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Abstract
Severe acute |
37 KB |
2020-09-27 |
|
37 |
|
51 |
2021-01-19
|
PMC |
7361216 |
A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan t |
9.26 KB |
2020-11-19 |
|
36 |
|
3 |
2021-01-19
|
PMC |
7441788 |
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
J. SUN ET AL |
42.1 KB |
2020-09-27 |
|
37 |
|
1 |
2021-01-19
|
PMC |
7443692 |
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
Abstract
The S |
72.3 KB |
2020-12-29 |
|
22 |
|
2,948 |
2021-01-19
|
PMC |
7556165 |
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Abstract
Angiotensin-converting |
77 KB |
2020-12-29 |
|
28 |
|
35 |
2021-01-19
|